Protein risk with GLP‑1s

These drugs work by making food feel less urgent. Semaglutide copies a gut hormone called glucagon-like peptide 1, and tirzepatide copies that signal plus a second one, glucose-dependent insulinotropic polypeptide, so people feel full sooner and eat less. (eurekalert.org) That appetite drop is the whole point of Wegovy and Zepbound. The United States labels for both drugs say they are meant to be used with a reduced-calorie diet and increased physical activity, not as stand-alone injections. (accessdata.fda.gov 1) (accessdata.fda.gov 2) Protein is the body’s repair material. Your muscles, skin, enzymes, and immune cells all depend on a steady supply of amino acids, which are the smaller building blocks that come from protein in food. (ajcn.nutrition.org) Weight loss already puts muscle at risk because the body is running on fewer calories. A 2025 joint advisory in The American Journal of Clinical Nutrition said nutritional and lifestyle support is needed during glucagon-like peptide 1 therapy to protect lean mass and avoid diet-quality problems. (ajcn.nutrition.org) The new warning sign came from real-world food logs, not a tightly controlled drug trial. Researchers in Italy analyzed app-based diet records from 116 people taking semaglutide or tirzepatide and compared them with 177 people with overweight or obesity who were not taking those drugs. (eurekalert.org) People on the drugs ate less across the board, but protein fell with everything else. The study found 88% of users were below national protein guidelines, compared with 69% of non-users, and users skipped meals more often, which cut down the number of chances to eat protein during the day. (eurekalert.org) The researchers also said these medicines can cut calorie intake by about 16% to 39%. If breakfast becomes coffee, lunch becomes half a yogurt, and dinner becomes a few bites, protein can end up low even when weight loss looks successful on a scale. (eurekalert.org) Doctors and dietitians are now giving a very practical message: don’t wait for hunger to guide you. A Today report published April 10, 2026 said clinicians are telling people on these drugs to plan protein first because reduced appetite makes “what they eat more important than ever.” (today.com) This is not just about gym performance. The European Congress on Obesity abstract linked low intake to wider nutritional shortfalls, and researchers flagged possible downstream problems such as fatigue, hair loss, slow wound healing, weaker immunity, and bone risk when vitamins and minerals also slip. (eurekalert.org) The catch is that there is no one magic number that fits everyone. The study team said protein targets should be personalized in grams per kilogram of adjusted body weight, which means a clinician has to match the goal to the patient instead of handing out the same target to everyone in the waiting room. (eurekalert.org) So the story is shifting from “these drugs make you eat less” to “these drugs make every bite count more.” The people doing best may be the ones who treat semaglutide or tirzepatide less like appetite erasers and more like medicines that require an actual eating plan. (ajcn.nutrition.org) (today.com)